Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001181186-26-000008

Director acquired 302 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

YARNO WENDY L · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-15 Exercise or conversion : show line 1 in the form +302 16,956 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-15 Exercise or conversion : show line 2 in the form Restricted Stock Units −302 907 D
Loading xslF345X06/wk-form4_1789676577.xml…